Literature DB >> 7588960

Complications of percutaneous liver biopsy in infants and children.

A Lachaux1, C Le Gall, M Chambon, F Regnier, I Loras-Duclaux, R Bouvier, M Pinzaru, D Stamm, M Hermier.   

Abstract

UNLABELLED: In this study, 144 consecutive percutaneous liver biopsies performed with a 1.6 mm Menghini needle, during a 2-year period were reviewed. All the children were aged under 15 years, 57 patients less than 1 year and 87 more than 1 year. All biopsies were adequate and the mean number of portal tracts examined was 17.6 per biopsy (14.3 in patients weighing less than 10 kg and 19.1 in the others). There were no deaths and we observed only bleeding complications. In patients with normal coagulation (128 cases), 1 bleeding requiring transfusion occurred; and in patients with abnormal coagulation (16 cases), we observed 2 bleeding cases requiring transfusion.
CONCLUSION: Percutaneous liver biopsy can be performed with 1.6 mm needles in children. For increased safety, ultrasound-guided biopsies are recommended.

Entities:  

Mesh:

Year:  1995        PMID: 7588960     DOI: 10.1007/BF02079063

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Transjugular liver biopsy in children.

Authors:  K N Furuya; P E Burrows; M J Phillips; E A Roberts
Journal:  Hepatology       Date:  1992-06       Impact factor: 17.425

2.  Morbidity after percutaneous liver biopsy.

Authors:  S Lichtman; C Guzman; D Moore; J L Weber; E A Roberts
Journal:  Arch Dis Child       Date:  1987-09       Impact factor: 3.791

Review 3.  [Which procedures should be chosen for puncture-biopsy of the liver?].

Authors:  F Degos; J P Benhamou
Journal:  Gastroenterol Clin Biol       Date:  1993

4.  Bile peritonitis: another complication after fine-needle biopsy.

Authors:  T Livraghi; C Lombardi; G Mascia
Journal:  Diagn Imaging       Date:  1983

5.  [Complications of percutaneous liver puncture biopsy].

Authors:  D Chivrac; J P Capron
Journal:  Gastroenterol Clin Biol       Date:  1978-10

6.  Needle biopsy of the liver in infancy and childhood. A safe diagnostic aid in liver disease.

Authors:  W A Walker; W Krivit; H L Sharp
Journal:  Pediatrics       Date:  1967-12       Impact factor: 7.124

Review 7.  Paucity of interlobular bile ducts.

Authors:  M Hadchouel
Journal:  Semin Diagn Pathol       Date:  1992-02       Impact factor: 3.464

8.  Complications of percutaneous liver biopsy in children.

Authors:  M B Cohen; H H A-Kader; D Lambers; J E Heubi
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

9.  Outpatient percutaneous liver biopsy in children.

Authors:  R Gonzalez-Vallina; E M Alonso; E Rand; D D Black; P F Whitington
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-11       Impact factor: 2.839

10.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.

Authors:  F Piccinino; E Sagnelli; G Pasquale; G Giusti
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

  10 in total
  4 in total

1.  Laparoscopically assisted liver biopsy with a hemostatic plug.

Authors:  J S Karpelowsky; A Numanoglu; N M A Bax; H Rode
Journal:  Surg Endosc       Date:  2006-08-10       Impact factor: 4.584

2.  Keratin 18, Apoptosis, and Liver Disease in Children.

Authors:  Yanci O Mannery; Craig J McClain; Miriam B Vos
Journal:  Curr Pediatr Rev       Date:  2011-11

3.  Nonalcoholic fatty liver disease as a comorbidity of childhood obesity.

Authors:  Nicole J Barshop; Cameron S Francis; Jeffrey B Schwimmer; Joel E Lavine
Journal:  Ped Health       Date:  2009-06-01

4.  Aspartate aminotransferase to platelet ratio index correlates with hepatic cirrhosis but not with fibrosis in pediatric patients with intestinal failure.

Authors:  Juan J Díaz; Kathleen M Gura; Juliamna Roda; Antonio R Perez-Atayde; Christopher Duggan; Tom Jaksic; Clifford W Lo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-09       Impact factor: 2.839

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.